Company AB Science

AB

FR0010557264

Pharmaceuticals

Real-time Euronext Paris Other stock markets 03:39:57 2026-06-26 EDT			5-day change	1st Jan Change
0.8600 ^EUR	+0.23%		-3.91%	-44.01%

06-18	AB Science Secures US Patent for Prostate Cancer Therapy	MT
06-18	AB Science Secures New U.S. Patent for Masitinib

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 31

Sales by Activity: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	1.61M	958K	970K	1.07M	1.17M

See all business segments

Geographical breakdown of sales: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Europe	-	-	-	-	955K
outside Europe	-	-	-	-	219K

See all geographic segments

Executive Committee: AB Science

Manager	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	2001-07-10
Laurent Guy DFI	Director of Finance/CFO	-	2009-11-19
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	2018-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	2001-07-10
Patrick Moussy BRD	Director/Board Member	-	2011-09-19
Cécile de Guillebon BRD	Director/Board Member	64	2021-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	68	2021-06-26
Guillemette Latscha BRD	Director/Board Member	-	2021-06-26
Renaud Sassi BRD	Director/Board Member	-	2021-06-26

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
Jean-Claude Marian 10.41 %	6,888,610	10.41 %	8 M €
UBS Wealth Management SGIIC SA 0.004684 %	3,100	0.004684 %	3 487 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	33 313 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	20 496 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AB SCIENCE	+0.23%	-3.91%	-31.85%	-78.82%	74.76M
MERCK & CO., INC.	+4.02%	+10.17%	+57.46%	+9.47%	310B
MERCK KGAA	-2.24%	+8.77%	+29.47%	-5.28%	72.76B
HALOZYME THERAPEUTICS, INC.	+2.09%	+5.96%	+38.83%	+112.76%	8.62B
KYOWA KIRIN CO., LTD.	-0.43%	+0.43%	+2.99%	-6.70%	8.29B
SK BIOPHARMACEUTICALS CO., LTD.	+2.31%	-0.11%	-4.11%	+4.85%	4.5B
BETTA PHARMACEUTICALS CO., LTD.	+4.94%	+12.50%	+7.58%	+29.39%	3.83B
YUHAN CORPORATION	-1.38%	-8.82%	-30.10%	+29.30%	3.45B
SUPERNUS PHARMACEUTICALS, INC.	-0.86%	+0.83%	+43.25%	+37.14%	2.6B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+2.36%	+10.87%	+13.02%	-20.42%	2.12B
Average	+1.11%	+4.14%	+12.65%	+11.17%	41.61B
Weighted average by Cap.	+2.71%	+5.43%	+48.91%	+9.01%